Availability of safe and highly effective SARS-CoV-2 vaccines increased the possibility of durable control of COVID-19 both in the US and worldwide. After initial challenges in vaccine supply and delivery, there was substantial progress in vaccinating US residents. The arrival of spring 2021 and increasing vaccination rates, particularly among individuals at high risk for severe infection and complications, was followed by a steady decline in cases, hospitalizations, and deaths.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Carlos del Rio, MD, Emory University School of Medicine, 49 Jesse Hill Jr Dr SE, FOB Room 201, Atlanta, GA 30303 (firstname.lastname@example.org).
Published Online: August 18, 2021. doi:10.1001/jama.2021.14811
Conflict of Interest Disclosures: Dr del Rio reported receiving grants from the NIH/NIAID Emory Vaccine and Treatment Evaluation Unit. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.